Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
43 participants
OBSERVATIONAL
2017-12-22
2021-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bactiseal Catheter Safety Registry Study
NCT06276543
the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration
NCT05126446
Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device
NCT01478061
The Study on the Safety and Efficacy of the G-iliac Iliac Bifurcation Stent Graft System
NCT06660927
Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system
NCT02011984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No-React Non-valved Conduit
Operative replacement of infected graft or implantation in infected area.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High risk of infection at graft implantation
* Mycotic aneurysm
* No alternative available
Exclusion Criteria
* AV access
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catharina Ziekenhuis Eindhoven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marc van Sambeek
prof. dr. M.R.H.M. van Sambeek
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catharina Ziekenhuis
Eindhoven, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL59973.100.16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.